Viewing Study NCT00982566


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-02-23 @ 4:29 PM
Study NCT ID: NCT00982566
Status: COMPLETED
Last Update Posted: 2017-11-21
First Post: 2009-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoid Malignancy View
None Solid Tumors View
Keywords: